Stay updated on Upadacitinib vs Abatacept in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Abatacept in RA Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- The Sweden location entry now uses Malmö (with the diacritic) instead of Malmo, aligning the listing with the official city spelling. The postal code remains 214 28 and the rest of the details are unchanged.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a backend/content-system version change rather than any change to the trial information.SummaryDifference0.0%

- Check25 days agoChange DetectedKrakow, Lesser Poland Voivodeship, Poland, 30-149 is replaced by Cracow, Lesser Poland Voivodeship, Poland, 30-149. București is replaced by Bucharest, and a new Bucharest, Bucharest, Romania, 020475 entry is added; Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1 banner.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib vs Abatacept in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.